Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ann Palliat Med ; 10(4): 4768-4776, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33894723

RESUMO

BACKGROUND: Chylothorax is caused by accumulation of chylous fluid in the thoracic cavity following injury to the thoracic duct or its tributaries. It is a rare but relatively severe complication of lung cancer surgery, especially after lung resection and mediastinal lymph node dissection. If chylothorax is not treated promptly and effectively, it may result in relatively high mortality rate. Although the majority of patients with chylothorax secondary to lung cancer surgery can be treated with conservative measures, there are still some patients who fail to respond to conservative treatment or suffer from recurrent episodes. This study aims to explore the causes of postoperative chylothorax and how targeted treatment can help achieve better outcomes. METHODS: Four cases of chylothorax secondary to lung cancer surgery are reported in which patients underwent direct lymphangiography (DLG) after failed conservative treatment. RESULTS: Thoracic duct obstruction was found in all patients on DLG, as well as dilated intrathoracic part of the thoracic duct. Thoracic duct reconstruction was performed to successfully treat 3 of the 4 patients. CONCLUSIONS: DLG is of great value in the diagnosis of chylothorax secondary to lung cancer surgery, for which thoracic duct reconstruction proves to be an effective procedure. DLG provides a new objective basis for the diagnosis and treatment of chylothorax. It is our best wish to help more patients with chylothorax secondary to lung cancer surgery.


Assuntos
Quilotórax , Neoplasias Pulmonares , Quilotórax/diagnóstico por imagem , Quilotórax/etiologia , Quilotórax/terapia , Humanos , Linfografia , Complicações Pós-Operatórias , Ducto Torácico/diagnóstico por imagem , Ducto Torácico/cirurgia
2.
J Orthop Res ; 39(11): 2465-2473, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33382130

RESUMO

Receptor activator of nuclear factor kappa-B ligand (RANKL) is one of the key factors regulating the maturation of osteoclasts and an important target for osteoporosis treatment. A monoclonal antibody against RANKL showed effective therapeutic activity against osteoporosis by inhibiting bone resorption by osteoclasts. However, being an exogenous protein, its efficacy decreases after long-term use, and its discontinuation increases the risk of vertebral fractures. Here, we aimed to design an active immunotherapeutic agent to induce a T-cell dependent primary response. The agent, a mutant RANKL vaccine (mRv), was produced by cross-linking mutant RANKL, lacking the ability to stimulate osteoclast maturation, with the carrier protein keyhole limpet hemocyanin, a neo-antigen with a large molecular mass. Subcutaneous injection of mRv stimulated rats with ovariectomy-induced osteoporosis to produce high titers of anti-RANKL antibodies. The mutant RANKL vaccine decreased serum CTX-1 and BALP levels and inhibited the microstructural degeneration of trabecular bone in osteoporotic rats. mRv overcame immune system tolerance, stimulated rats to produce therapeutic antibodies, stabilized bone metabolism, and inhibited trabecular microstructural degeneration. These findings confirm the potential of the mutant RANKL vaccine to be developed into an effective preventive and therapeutic agent for osteoporosis.


Assuntos
Conservadores da Densidade Óssea , Reabsorção Óssea , Osteoporose , Vacinas , Animais , Conservadores da Densidade Óssea/farmacologia , Reabsorção Óssea/metabolismo , Reabsorção Óssea/prevenção & controle , Diferenciação Celular , Feminino , Humanos , Ligantes , NF-kappa B/metabolismo , Osteoclastos/fisiologia , Osteoporose/tratamento farmacológico , Osteoporose/prevenção & controle , Ovariectomia , Ligante RANK/metabolismo , Ratos , Vacinas/metabolismo , Vacinas/farmacologia , Vacinas/uso terapêutico
3.
Int J Biometeorol ; 63(5): 687-699, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-29236152

RESUMO

Artemisia pollen is an important allergen responsible for allergic rhinitis in Beijing, China. To explore the transport pathways and source areas of Artemisia pollen, we used Burkard 7-day traps to monitor daily pollen concentrations in 2016 in an urban and suburban locality. Backward trajectories of 24- and 96-h and their cluster analysis were performed to identify transport pathways of Artemisia pollen using the HYSPLIT model on 0.5° × 0.5° GADS meteorological data. The potential source contribution function (PSCF) and concentration weighted trajectory (CWT) were calculated to further identify the major potential source areas at local, regional, and long-range scales. Our results showed significant differences in Artemisia pollen concentration between urban and suburban areas, attributed to differences in plant distribution and altitude of the sampling locality. Such differences arisen from both pollen emission and air mass movements, hence pollen dispersal. At local or regional scales, source area of northwestern parts of Beijing City, Hebei Province and northern and northwestern parts of Inner Mongolia influenced the major transport pathways of Artemisia pollen. Transport pathway at a long-range scale and its corresponding source area extended to northwestern parts of Mongolia. The regional-scale transport affected by wind and altitude is more profound for Artemisia pollen at the suburban than at the urban station.


Assuntos
Poluentes Atmosféricos/análise , Alérgenos/análise , Artemisia , Pólen , Altitude , Pequim , Monitoramento Ambiental , Vento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA